Controlled Trial of Omadacycline Randomized Treatment Given for Bone and Joint Infection

Recruiting

Phase 2

OmadacyclineControlled Trial of Omadacycline Randomized Treatment Given for Bone and Joint Infection

Sponsor:

UCLA

Code:

NCT05753215

Conditions

Bone Infection

Joint Infection

Bone and Joint Infection

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Omadacycline Pill

Standard of Care

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-01. This information was provided to ClinicalTrials.gov by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center on 2025-03-10.